Evidence map›Paper›PMID 39478773›Full record

ArticleJournal of clinical and translational science2024

Health equity engineering: Optimizing hope for a new generation of healthcare.

Felicity T Enders, Elizabeth H Golembiewski, Joyce E Balls-Berry, Tayla R Brooks, Allison R Carr, John P Cullen, Deborah DiazGranados, Ayorkor Gaba, Leigh Johnson, Terri Menser and 8 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Felicity T EndersDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-3261-5400
Elizabeth H GolembiewskiDivision of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0003-1015-3935
Joyce E Balls-BerryDepartment of Neurology, Washington University School of Medicine, St. Louis. MO, USA.
Tayla R BrooksCenter for Clinical and Translational Science, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, USA.
Allison R CarrCenter for Clinical and Translational Science, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, USA.
John P CullenClinical and Translational Science Institute, Center for Community Health and Prevention and Health Humanities and Bioethics, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-5453-170X
Deborah DiazGranadosSchool of Medicine, Virginia Commonwealth University, Richmond, VA, USA.ORCID https://orcid.org/0000-0002-0624-7093
Ayorkor GabaDepartment of Counseling & Clinical Psychology, Teachers College, Columbia University, New York, NY, USA.ORCID https://orcid.org/0000-0001-5471-8278
Leigh JohnsonClinical & Translational Science Institute, New York University Langone Health, New York, NY, USA.
Terri MenserDivision of Health Care Delivery, Mayo Clinic, Jacksonville, FL, USA.
Shari MessingerDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Adam J MilamDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
Minerva A OrellanaDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.ORCID https://orcid.org/0000-0002-0152-7117
Susan M PerkinsDepartment of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA.
Tiffany D Chisholm PinedaCollege of Journalism, University of Florida, Gainesville, FL, USA.ORCID https://orcid.org/0000-0003-4759-227X
Sally W ThurstonDepartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA.
Vyjeyanthi S PeriyakoilDepartment of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
Alexandra L HanlonDepartment of Statistics, Virginia Tech, Blacksburg, VA, USA.

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Sally W Thurston · 1985 to 2026
$42.8M
NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

Medical researchers are increasingly prioritizing the inclusion of underserved communities in clinical studies. However, mere inclusion is not enough. People from underserved communities frequently experience chronic stress that may lead to accelerated biological aging and early morbidity and mortality. It is our hope and intent that the medical community come together to engineer improved health outcomes for vulnerable populations. Here, we introduce Health Equity Engineering (HEE), a comprehensive scientific framework to guide research on the development of tools to identify individuals at risk of poor health outcomes due to chronic stress, the integration of these tools within existing healthcare system infrastructures, and a robust assessment of their effectiveness and sustainability. HEE is anchored in the premise that strategic intervention at the individual level, tailored to the needs of the most at-risk people, can pave the way for achieving equitable health standards at a broader population level. HEE provides a scientific framework guiding health equity research to equip the medical community with a robust set of tools to enhance health equity for current and future generations.

Indexed as

accelerated agingchronic stresshealth disparitiesHealth equitypopulation health

Identifiers

PMID39478773
PMCPMC11523014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.